Trials / Not Yet Recruiting
Not Yet RecruitingNCT07385248
A Clinical Trial to Assess the Pharmacokinetics and Safety of AD-229 Compared to AD-2291 in Healthy Adults
An Open-label, Randomized, 2-treatment, 2-sequence, 2-period, Crossover Study to Evaluate the Pharmacokinetics and Safety Between the Administration of AD-229 and the Administration of AD-2291 for Healthy Adults in Fasting State
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (estimated)
- Sponsor
- Addpharma Inc. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
The study compare and evaluate the safety and pharmacokinetic characteristics between the administration of AD-229 and the administration of AD-2291 in healthy adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AD-229 | AD-229 Oral Tablet |
| DRUG | AD-2291 | AD-2291 Oral Tablet |
Timeline
- Start date
- 2026-04-01
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
- First posted
- 2026-02-04
- Last updated
- 2026-02-27
Source: ClinicalTrials.gov record NCT07385248. Inclusion in this directory is not an endorsement.